CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Eduardo Pérez-Gómez - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Eduardo Pérez-Gómez

OPENALEX: A5062727922↗ORCID: 0000-0003-0160-5565↗

Affiliations

Organizations

Biomedical Research Networking Center on Neurodegenerative Diseasesauthorship · ES Instituto Ramón y Cajal de Investigación Sanitariaauthorship · ES Research Institute Hospital 12 de Octubreauthorship · ES Universidad Complutense de Madridauthorship · ES

Public evidence

3 connected articles

Cannabinoid CB<sub>2</sub> receptor drives trastuzumab resistance and predicts durable anti-HER2 response.2026 · Europe PMC Fatty acid amide hydrolase drives adult mammary gland development by promoting luminal cell differentiation.2024 · Europe PMC Neuronal Cannabinoid CB<sub>1</sub> Receptors Suppress the Growth of Melanoma Brain Metastases by Inhibiting Glutamatergic Signalling.2023 · Europe PMC

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.